DK39892D0 - Peptid - Google Patents

Peptid

Info

Publication number: DK39892D0
Authority: DK; Denmark
Prior art keywords: glp; pct; agonists; receptor; sec
Prior art date: 1992-03-25

Application number

DK92398A

Other languages

English (en)

Inventor

Bernard Thorens

Original Assignee

Bernard Thorens

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-25

Filing date

1992-03-25

Publication date

1992-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8093079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK39892(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-03-25 Application filed by Bernard Thorens filed Critical Bernard Thorens

1992-03-25 Priority to DK92398A priority Critical patent/DK39892D0/da

1992-03-25 Publication of DK39892D0 publication Critical patent/DK39892D0/da

1993-03-23 Priority to US08/142,439 priority patent/US5670360A/en

1993-03-23 Priority to DE69326405T priority patent/DE69326405T2/de

1993-03-23 Priority to PCT/EP1993/000697 priority patent/WO1993019175A1/en

1993-03-23 Priority to DE0586657T priority patent/DE586657T1/de

1993-03-23 Priority to JP51628793A priority patent/JP3371379B2/ja

1993-03-23 Priority to AT93906589T priority patent/ATE184648T1/de

1993-03-23 Priority to AU37512/93A priority patent/AU3751293A/en

1993-03-23 Priority to EP93906589A priority patent/EP0586657B1/en

1993-03-23 Priority to ES93906589T priority patent/ES2070801T1/es

1995-06-30 Priority to GR950300031T priority patent/GR950300031T1/el

1997-06-05 Priority to US08/869,477 priority patent/US5846747A/en

1997-09-22 Priority to US08/935,317 priority patent/US6051689A/en

Links

108090000765 processed proteins & peptides Proteins 0.000 title 1
102000007446 Glucagon-Like Peptide-1 Receptor Human genes 0.000 abstract 2
108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 abstract 2
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 2
101800000224 Glucagon-like peptide 1 Proteins 0.000 abstract 2
102100040918 Pro-glucagon Human genes 0.000 abstract 2
239000000556 agonist Substances 0.000 abstract 2
238000012216 screening Methods 0.000 abstract 2
108020004414 DNA Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/605—Glucagons
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DK92398A 1992-03-25 1992-03-25 Peptid DK39892D0 (da)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
DK92398A DK39892D0 (da)	1992-03-25	1992-03-25	Peptid
ES93906589T ES2070801T1 (es)	1992-03-25	1993-03-23	Receptor para el peptido-1 similar al glucagon (glp-1).
EP93906589A EP0586657B1 (en)	1992-03-25	1993-03-23	Receptor for the glucagon-like-peptide-1 (glp-1)
JP51628793A JP3371379B2 (ja)	1992-03-25	1993-03-23	グルカゴン様ペプチド−１（ｇｌｐ−１）に対するレセプター
DE69326405T DE69326405T2 (de)	1992-03-25	1993-03-23	Receptor für das Glucagon ähnliches Peptid-1 (GLP-1)
PCT/EP1993/000697 WO1993019175A1 (en)	1992-03-25	1993-03-23	Receptor for the glucagon-like-peptide-1 (glp-1)
DE0586657T DE586657T1 (de)	1992-03-25	1993-03-23	Receptor für das Glucagon ähnliches Peptid-1 (GLP-1).
US08/142,439 US5670360A (en)	1992-03-25	1993-03-23	Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers
AT93906589T ATE184648T1 (de)	1992-03-25	1993-03-23	Receptor für das glucagon ähnliches peptid-1 (glp-1)
AU37512/93A AU3751293A (en)	1992-03-25	1993-03-23	Receptor for the glucagon-like-peptide-1 (GLP-1)
GR950300031T GR950300031T1 (en)	1992-03-25	1995-06-30	Receptor for the glucagon-like-peptide-1 (glp-1).
US08/869,477 US5846747A (en)	1992-03-25	1997-06-05	Method for detecting glucagon-like peptide-1 antagonists and agonists
US08/935,317 US6051689A (en)	1992-03-25	1997-09-22	Receptor for the glucagon-like-peptide (GLP-1)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK92398A DK39892D0 (da)	1992-03-25	1992-03-25	Peptid

Publications (1)

Publication Number	Publication Date
DK39892D0 true DK39892D0 (da)	1992-03-25

Family

ID=8093079

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92398A DK39892D0 (da)	1992-03-25	1992-03-25	Peptid

Country Status (10)

Country	Link
US (2)	US5670360A (da)
EP (1)	EP0586657B1 (da)
JP (1)	JP3371379B2 (da)
AT (1)	ATE184648T1 (da)
AU (1)	AU3751293A (da)
DE (2)	DE69326405T2 (da)
DK (1)	DK39892D0 (da)
ES (1)	ES2070801T1 (da)
GR (1)	GR950300031T1 (da)
WO (1)	WO1993019175A1 (da)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5614492A (en) *	1986-05-05	1997-03-25	The General Hospital Corporation	Insulinotropic hormone GLP-1 (7-36) and uses thereof
US6849708B1 (en)	1986-05-05	2005-02-01	The General Hospital Corporation	Insulinotropic hormone and uses thereof
US7138486B2 (en)	1986-05-05	2006-11-21	The General Hospital Corporation	Insulinotropic hormone derivatives and uses thereof
DK39892D0 (da) *	1992-03-25	1992-03-25	Bernard Thorens	Peptid
US5846747A (en) *	1992-03-25	1998-12-08	Novo Nordisk A/S	Method for detecting glucagon-like peptide-1 antagonists and agonists
CZ315594A3 (en) *	1992-06-15	1995-07-12	Pfizer	Peptide of glucagon type, insulinotropic derivatives, process of their preparation, pharmaceutical composition containing such compounds and use
AU689078B2 (en) *	1992-08-28	1998-03-26	Novo Nordisk A/S	Glucagon receptors
US6284727B1 (en)	1993-04-07	2001-09-04	Scios, Inc.	Prolonged delivery of peptides
JPH09501054A (ja) *	1993-08-09	1997-02-04	メルクエンドカンパニーインコーポレーテッド	ヒトグルカゴン様１ペプチドレセプター
GB9502830D0 (en) *	1995-02-14	1995-04-05	Ecole Polytech	Regulation of polypeptide production in cells
US7048906B2 (en)	1995-05-17	2006-05-23	Cedars-Sinai Medical Center	Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
DK0946591T3 (da) *	1996-12-13	2007-08-13	Nps Allelix Corp	Klonede glucagon-lignende peptid-2 receptorer
US8592553B2 (en)	1996-12-13	2013-11-26	Nps Pharmaceuticals, Inc.	Cloned glucagon-like peptide-2 receptors
DE69911975T2 (de)	1998-07-31	2004-09-09	Novo Nordisk A/S	In-vitro stimulation von beta zellen vermehrung
WO2000025134A1 (en) *	1998-10-23	2000-05-04	Glaxo Group Limited	Assays for ligands for nuclear receptors
EP1634605A3 (en)	2000-03-08	2006-10-11	Novo Nordisk A/S	treatment of dyslipidemia in a patient having type 2 diabetes
US6448045B1 (en) *	2000-03-10	2002-09-10	The Regents Of The University Of California	Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
US20020123071A1 (en) *	2000-12-04	2002-09-05	Knudsen Sanne Moller	Method of identifying compounds capable of acting as agonists or antagonists of G-protein coupled receptors
US6642003B2 (en)	2001-08-02	2003-11-04	Cedars-Sinai Medical Center	Human glucose-dependent insulin-secreting cell line
DE60230818D1 (de)	2001-09-24	2009-02-26	Imp Innovations Ltd	Pyy3-36 zur zur reduzierung oder vorbeugung von fettleibigkeit
US6911324B2 (en) *	2001-10-18	2005-06-28	The Regents Of The University Of California	Induction of beta cell differentiation in human cells
EP1474163A2 (en)	2002-01-10	2004-11-10	Imperial College Innovations Limited	Modification of feeding behavior
US7141240B2 (en) *	2002-03-12	2006-11-28	Cedars-Sinai Medical Center	Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
ATE432289T1 (de)	2002-07-04	2009-06-15	Zealand Pharma As	Glp-1 und behandlungsmethode für diabetes
AU2003268621B2 (en)	2002-10-02	2009-01-15	Zealand Pharma A/S	Stabilized exendin-4 compounds
US20040209803A1 (en) *	2002-12-19	2004-10-21	Alain Baron	Compositions for the treatment and prevention of nephropathy
US7790681B2 (en) *	2002-12-17	2010-09-07	Amylin Pharmaceuticals, Inc.	Treatment of cardiac arrhythmias with GLP-1 receptor ligands
GB0300571D0 (en)	2003-01-10	2003-02-12	Imp College Innovations Ltd	Modification of feeding behaviour
WO2004071393A2 (en) *	2003-02-13	2004-08-26	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with glucagon-like peptide 1 receptor (glp1r)
WO2005018536A2 (en) *	2003-05-23	2005-03-03	Human Genome Sciences, Inc.	Agonist antibodies that specifically bind the glucagon like peptide-1 receptor
SI3300721T2 (sl)	2003-11-20	2025-05-30	Novo Nordisk A/S	Peptidne formulacije, ki vsebujejo propilen glikol in ki so optimalne za proizvodnjo in uporabo v napravah za injiciranje
WO2005056036A2 (en)	2003-12-09	2005-06-23	Novo Nordisk A/S	Regulation of food preference using glp-1 agonists
EP2316446A1 (en)	2004-06-11	2011-05-04	Novo Nordisk A/S	Counteracting drug-induced obesity using GLP-1 agonists
EP1896605A4 (en)	2005-06-07	2010-09-01	Univ Rockefeller	Stimulation of proliferation of pancreatic B cells
TWI428346B (zh)	2006-12-13	2014-03-01	Imp Innovations Ltd	新穎化合物及其等對進食行為影響
WO2009126709A1 (en) *	2008-04-09	2009-10-15	Transtech Pharma, Inc.	Ligands for the glp-1 receptor and methods for discovery thereof
PT2349324T (pt)	2008-10-17	2017-12-06	Sanofi Aventis Deutschland	Combinação de uma insulina e de um agonista do glp-1
SG10201500871TA (en)	2009-11-13	2015-04-29	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2011058083A1 (de)	2009-11-13	2011-05-19	Sanofi-Aventis Deutschland Gmbh	Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
WO2011123943A1 (en)	2010-04-09	2011-10-13	Mount Sinai Hospital	Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
AU2011247452B2 (en)	2010-04-27	2016-03-17	Zealand Pharma A/S	Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
RS55378B1 (sr)	2010-08-30	2017-03-31	Sanofi Aventis Deutschland	Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
RS56998B1 (sr)	2010-12-16	2018-05-31	Novo Nordisk As	Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HRP20151068T1 (hr)	2011-08-29	2016-01-01	Sanofi-Aventis Deutschland Gmbh	Farmaceutska kombinacija za upotrebu za glikemijsku kontrolu kod pacijenata s dijabetesom tipa 2
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
MX2014005351A (es)	2011-11-03	2014-05-28	Zealand Pharma As	Conjugados de gastrina peptidicos de agonistas de receptor glp-1.
US20150038417A1 (en)	2011-12-09	2015-02-05	Novo Nordisk A/S	GLP-1 Agonists
WO2013139695A1 (en)	2012-03-22	2013-09-26	Novo Nordisk A/S	Compositions comprising a delivery agent and preparation thereof
CN104203266B (zh)	2012-03-22	2017-12-26	诺和诺德股份有限公司	Glp‑1肽组合物及其制备
PL2866825T3 (pl)	2012-07-01	2021-02-22	Novo Nordisk A/S	<div>ZASTOSOWANIE PEPTYDÓW GLP-1 O PRZEDŁUŻONYM DZIAŁANIU</div>
IN2015DN00544A (da)	2012-07-23	2015-06-26	Zealand Pharma As
TWI608013B (zh)	2012-09-17	2017-12-11	西蘭製藥公司	升糖素類似物
US20150273069A1 (en)	2012-10-17	2015-10-01	Novo Nordisk A/S	Fatty acid acylated amino acids for oral peptide delivery
TWI641381B (zh)	2013-02-04	2018-11-21	法商賽諾菲公司	胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
ES2688708T3 (es)	2013-10-17	2018-11-06	Zealand Pharma A/S	Análogos de glucagón acilados
US9988429B2 (en)	2013-10-17	2018-06-05	Zealand Pharma A/S	Glucagon analogues
US10131702B2 (en)	2013-11-06	2018-11-20	Zealand Pharma A/S	Glucagon-GLP-1-GIP triple agonist compounds
EP3065767B1 (en)	2013-11-06	2020-12-30	Zealand Pharma A/S	Gip-glp-1 dual agonist compounds and methods
RU2016132340A (ru)	2014-01-09	2018-02-14	Санофи	Стабилизированные фармацевтические составы на основе инсулина аспарта
SG11201604710XA (en)	2014-01-09	2016-07-28	Sanofi Sa	Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604708VA (en)	2014-01-09	2016-07-28	Sanofi Sa	Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
DK3006045T3 (da)	2014-10-07	2017-07-17	Cyprumed Gmbh	Farmaceutiske formuleringer til oral indgivelse af peptid- eller proteinlægemidler
US10253078B2 (en)	2014-10-29	2019-04-09	Zealand Pharma A/S	GIP agonist compounds and methods
TWI758239B (zh)	2014-12-12	2022-03-21	德商賽諾菲阿凡提斯德意志有限公司	甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
PL3283507T3 (pl)	2015-04-16	2020-05-18	Zealand Pharma A/S	Acylowany analog glukagonu
JP2018529749A (ja)	2015-10-07	2018-10-11	シプルメット・ゲーエムベーハー	ペプチド薬物を経口送達するための医薬製剤
WO2018065634A1 (en)	2016-10-07	2018-04-12	Cyprumed Gmbh	Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
SG11201903938XA (en)	2016-12-09	2019-05-30	Zealand Pharma As	Acylated glp-1/glp-2 dual agonists
MX2020001525A (es)	2017-08-24	2020-03-20	Novo Nordisk As	Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
BR112020014624A2 (pt)	2018-02-02	2020-12-08	Novo Nordisk A/S	Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante
WO2019193204A1 (en)	2018-04-06	2019-10-10	Cyprumed Gmbh	Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
TWI829687B (zh)	2018-05-07	2024-01-21	丹麥商諾佛儂迪克股份有限公司	包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
CN111423506B (zh) *	2019-11-08	2023-06-27	成都奥达生物科技有限公司	一种glp-1化合物
IL294521A (en)	2020-02-18	2022-09-01	Novo Nordisk As	glp-1 compounds and their uses
US11478533B2 (en)	2020-04-27	2022-10-25	Novo Nordisk A/S	Semaglutide for use in medicine
JP7777085B2 (ja)	2020-04-29	2025-11-27	ノヴォノルディスクアー／エス	Ｇｌｐ－１作動薬およびヒスチジンを含む固形組成物
WO2022049310A1 (en)	2020-09-07	2022-03-10	Cyprumed Gmbh	Improved pharmaceutical formulations of glp-1 receptor agonists
WO2023012263A1 (en)	2021-08-04	2023-02-09	Novo Nordisk A/S	Solid oral peptide formulations
AU2023415591A1 (en)	2022-12-30	2025-08-14	Algipharma As	Compositions and methods to increase the systemic bioavailability of a polypeptide therapeutic agent undergoing oral administration
WO2024165571A2 (en)	2023-02-06	2024-08-15	E-Therapeutics Plc	Inhibitors of expression and/or function
WO2025125576A2 (en)	2023-12-15	2025-06-19	E-Therapeutics Plc	Inhibitors of expression and/or function
EP4686757A1 (en)	2024-07-31	2026-02-04	e-therapeutics PLC	Inhibitors of expression and/or function
WO2025133348A1 (en)	2023-12-22	2025-06-26	E-Therapeutics Plc	Inhibitors of expression and/or function
WO2025196502A1 (en)	2024-03-20	2025-09-25	North Carolina Agricultural & Technical State University	Choline kinase inhibitors as a therapeutic treatment for obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK39892D0 (da) *	1992-03-25	1992-03-25	Bernard Thorens	Peptid

1992
- 1992-03-25 DK DK92398A patent/DK39892D0/da not_active Application Discontinuation
1993
- 1993-03-23 JP JP51628793A patent/JP3371379B2/ja not_active Expired - Lifetime
- 1993-03-23 DE DE69326405T patent/DE69326405T2/de not_active Expired - Lifetime
- 1993-03-23 AU AU37512/93A patent/AU3751293A/en not_active Abandoned
- 1993-03-23 EP EP93906589A patent/EP0586657B1/en not_active Expired - Lifetime
- 1993-03-23 DE DE0586657T patent/DE586657T1/de active Pending
- 1993-03-23 AT AT93906589T patent/ATE184648T1/de not_active IP Right Cessation
- 1993-03-23 ES ES93906589T patent/ES2070801T1/es active Pending
- 1993-03-23 WO PCT/EP1993/000697 patent/WO1993019175A1/en not_active Ceased
- 1993-03-23 US US08/142,439 patent/US5670360A/en not_active Expired - Lifetime
1995
- 1995-06-30 GR GR950300031T patent/GR950300031T1/el unknown
1997
- 1997-09-22 US US08/935,317 patent/US6051689A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0586657A1 (en)	1994-03-16
WO1993019175A1 (en)	1993-09-30
US6051689A (en)	2000-04-18
DE586657T1 (de)	1996-01-18
US5670360A (en)	1997-09-23
ES2070801T1 (es)	1995-06-16
JPH06508765A (ja)	1994-10-06
ATE184648T1 (de)	1999-10-15
EP0586657B1 (en)	1999-09-15
DE69326405D1 (de)	1999-10-21
DE69326405T2 (de)	2000-03-23
JP3371379B2 (ja)	2003-01-27
GR950300031T1 (en)	1995-06-30
AU3751293A (en)	1993-10-21

Publication	Publication Date	Title
DK39892D0 (da)	1992-03-25	Peptid
DK1482042T3 (da)	2009-06-15	Aktive og inaktive CC-kemokinreceptorer og nukleinsyremolekyler der koder for receptoren
DK0758383T3 (da)	2007-05-29	Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
IL112112A (en)	2000-06-29	Peptides with growth hormone releasing properties and pharmaceutical compositions containing them
DK0667910T3 (da)	2003-12-01	En Bacillus-promoter, afledt fra en variant af en alpha-amylase-promoter fra Bacillus licheniformis
DK0675956T3 (da)	2003-07-07	Nyt protein fra urin betegnet komponent B
ES2018750T3 (es)	1994-10-16	Un metodo de adn recombinante para la produccion de un antagonista de los receptores de interleucina 1 (il-li)
DK0591914T3 (da)	1999-08-16	Retrovirus fra HIV-gruppen og dets anvendelse
DK1294757T3 (da)	2007-03-19	Glucagonlignende peptid 1-analoger
DK0479948T3 (da)	1999-05-25	Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
ATE184022T1 (de)	1999-09-15	Neuropeptide y antagoniste
DE59101889D1 (de)	1994-07-14	Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
AU1208497A (en)	1997-07-28	Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
DK1282437T3 (da)	2008-06-30	Behandling af brusklidelser
DK0395853T3 (da)	1999-02-15	Rekombinant proteinreceptor
FI952094A0 (fi)	1995-05-02	Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
ATE225806T1 (de)	2002-10-15	D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DE59206628D1 (en)	1996-07-25	Expression signalpeptid-freier staphylokinasen
DE69526087D1 (de)	2002-05-02	Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ATE358682T1 (de)	2007-04-15	Klonierte rezeptoren des glukagon-ähnlichen peptids-2
FR2693200B1 (fr)	1994-08-19	Nouveaux polypeptides ayant une activité de récepteur sérotoninergique, acides nucléiques codant pour ces polypeptides et utilisations.
ES2059801T3 (es)	1994-11-16	Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
DK0487229T3 (da)	1997-12-29	DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet
NO940797L (no)	1994-03-07	Reseptorderivater som har bindingseter for human-rhinovirus

Legal Events

Date	Code	Title	Description
1992-10-26	AHS	Application shelved for other reasons than non-payment

DK39892D0 - Peptid - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (13)

Applications Claiming Priority (1)

Publications (1)

Family

ID=8093079

Family Applications (1)

Country Status (10)

Families Citing this family (87)

Family Cites Families (1)

Also Published As

Similar Documents

Legal Events